Benchmark Upgrades Incyte to Buy, Announces $89 Price Target
Benchmark analyst Aydin Huseynov upgrades Incyte (NASDAQ:INCY) from Hold to Buy and announces $89 price target.
Related Posts
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
Investors often short stocks to hedge positions against long positions or as a way to bet against a particular company. Benzinga provides a look at the most shorted stocks here.
Deutsche Bank Upgrades Bloomin Brands to Buy, Announces $34 Price Target
Deutsche Bank analyst Brian Mullen upgrades Bloomin Brands (NASDAQ:BLMN) from Hold to Buy and announces $34 price target.
Will The Santa Rally Lead Wall Street To New All-Time Highs Soon?
The S&P 500 and Nasdaq made new highs during a strong earnings season in November 2021, even with raising concerns about inflation and ongoing supply chain problems.
Trillion Dollar Companies Dominate The Market